Clinical Trial

Group PACBT for Depression

Name: Group PACBT for Depression — clinical trial record (NCT07566104)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study will seek to determine the (1) acceptability and (2) feasibility of psilocybin as an adjunct to cognitive-behavioral therapy, delivered as a group treatment (G-PACBT) for major depressive disorder and (3) explore the clinical effects of G-PACBT on depressive symptoms and psychosocial functioning.

Trial Details

NCT Number	NCT07566104
Lead Sponsor	University of California, Los Angeles
Conditions	Depression - Major Depressive Disorder, Psilocybin, Cognitive Behavioral Therapy
Enrollment	30 participants
Start Date	2027-01
Primary Completion	2028-12 (estimated)
Study Completion	2028-12 (estimated)
Updated on ClinicalTrials.gov	2026-05-04